Your browser doesn't support javascript.
loading
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results.
Rücker, Frank G; Du, Ling; Luck, Tamara J; Benner, Axel; Krzykalla, Julia; Gathmann, Insa; Voso, Maria Teresa; Amadori, Sergio; Prior, Thomas W; Brandwein, Joseph M; Appelbaum, Frederick R; Medeiros, Bruno C; Tallman, Martin S; Savoie, Lynn; Sierra, Jorge; Pallaud, Celine; Sanz, Miguel A; Jansen, Joop H; Niederwieser, Dietger; Fischer, Thomas; Ehninger, Gerhard; Heuser, Michael; Ganser, Arnold; Bullinger, Lars; Larson, Richard A; Bloomfield, Clara D; Stone, Richard M; Döhner, Hartmut; Thiede, Christian; Döhner, Konstanze.
Afiliação
  • Rücker FG; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Du L; Novartis Pharmaceuticals, Cambridge, MA, USA.
  • Luck TJ; Department of Hematology, Oncology and Tumor Immunology, Charité University, Berlin, Germany.
  • Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Gathmann I; Novartis Pharmaceuticals, Basel, Switzerland.
  • Voso MT; Department of Biomedicine and Prevention, Università di Roma "Tor Vergata", Rome, Italy.
  • Amadori S; Department of Biomedicine and Prevention, Università di Roma "Tor Vergata", Rome, Italy.
  • Prior TW; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Brandwein JM; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Medeiros BC; Division of Hematology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA, USA.
  • Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
  • Savoie L; University of Calgary, Calgary, AB, Canada.
  • Sierra J; Hematology Department, Hospital de la Santa Creu i Sant Pau and Jose Carreras Leukemia Research Institute, Autonomus University of Barcelona, Barcelona, Spain.
  • Pallaud C; Novartis Pharmaceuticals, Basel, Switzerland.
  • Sanz MA; Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia, Spain.
  • Jansen JH; Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Niederwieser D; Hematology and Oncology, University of Leipzig, Leipzig, Germany.
  • Fischer T; Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • Ehninger G; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.
  • Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité University, Berlin, Germany.
  • Larson RA; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Bloomfield CD; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Stone RM; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA.
  • Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Thiede C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.
  • Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. konstanze.doehner@uniklinik-ulm.de.
Leukemia ; 36(1): 90-99, 2022 01.
Article em En | MEDLINE | ID: mdl-34316017
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Mutagênese Insercional / Sequências de Repetição em Tandem / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Mutagênese Insercional / Sequências de Repetição em Tandem / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha